EGF receptor (EGFR) can be detected as overexpressed in some tumors, such as prostate cancer, bladder cancer, breast cancer, ovarian cancer, non-small cell lung cancer, and head and neck cancer, and has also been found to play an important role in the progression of several human malignancies [36]. This evidence concerns the gene EGFR and ovarian carcinoma.